跳至主要内容
临床试验/NCT03206554
NCT03206554已完成2 期

Local Infiltration Analgesia in Total Knee Arthroplasty: A Randomized, Prospective, Placebo Controlled, Double Blinded Study.

Asklepieion Voulas General Hospital0 个研究点目标入组 40 人开始时间: 2015年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
主要终点
Morphine consumption

研究概览

简要总结

40 patients ASA I-III, undergoing total knee arthroplasty were randomly assigned, into one of two groups, namely group LIA (n=20), where local infiltration analgesia would be administered intraoperatively; and group sham LIA (n=20), where sham injections of normal saline would be administered. All patients received a standardized multimodal approach, including pregabalin, adductor canal peripheral nervous blockade, spinal anaesthesia, paracetamol, and PCA with morphine. Morphine consumption during the first 24 hours postoperatively was measured and additionally the investigators recorded: Time of morphine first dose administration, NRS scores in static and dynamic conditions in 6 hours, 12 hours, 18 hours and 24 hours postoperatively, complications, patient satisfaction and duration of hospitalization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Physical status according to American Society of Anesthesiologists (ASA) I-III
  • Patients scheduled for total knee arthroplasty

排除标准

  • Contraindication for central and/or peripheral nervous blockade
  • Reoperation on previous total knee arthroplasty
  • History of allergic or other adverse reactions on the agents used in the study
  • Chronic opioid or gabapentinoid use
  • Serious psychiatric, mental and cognitive disorders
  • Language barrier
  • Difficulty in understanding or using a patient controlled analgesia device

研究组 & 干预措施

LIA

Active Comparator

Local infiltration analgesia

干预措施: Ropivacaine (Drug)

sham LIA

Sham Comparator

Saline injections

干预措施: Saline (Other)

结局指标

主要结局

Morphine consumption

时间窗: 24 hours

次要结局

  • Duration of hospitalization(1 month)
  • NRS scores(24 hours)
  • Complications(24 hours)
  • Patient satisfaction(24 hours)

研究者

发起方
Asklepieion Voulas General Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Alexandros Makris

Consultant Anaesthesiologist

Asklepieion Voulas General Hospital

相似试验